LGND Ligand completes acquisition of Xoma Royalty, creating a portfolio of more than 200 biopharmaceutical Royalty assets

LGND Ligand completes acquisition of Xoma Royalty, creating a portfolio of more than 200 biopharmaceutical Royalty assets